Newsgather
AtrásPakistan seeks to raise its global standing in push for Middle East peace
Pakistan seeks to raise its global standing in push for Middle East peace
NOTICIA
Guardian Business20/4/2026BusinessUnited Kingdom

Pakistan seeks to raise its global standing in push for Middle East peace

Tamaño de fuente

Islamabad has seized chance to act as mediator in Iran war and hopes to reap diplomatic and economic benefitsMiddle East crisis – live updatesAs Pakistan works frantically to narrow differences between Iran and the US in its newfound role as global peacemaker, it is also seeking to recast its diplomatic standing and attract business.Pakistani officials, mediating between an unpredictable US president and hardliners in Tehran, were on Monday trying to coax both sides to put the conditions in place for a second round of talks in Islamabad this week, including easing the standoff in the strait of Hormuz. Pakistan was optimistic that the meeting would happen, viewing objections voiced by the Iranian side and Donald Trump’s threats as posturing for domestic audiences. Continue reading...

Continue reading on Guardian Business
This article was originally published by Guardian Business.

Noticias relacionadas

Thames Water: Creditors' New Offers Highlight Government's Weak Approach
En desarrollo·hace 1 hora

Thames Water: Creditors' New Offers Highlight Government's Weak Approach

Thames Water bondholders, facing a credible threat of special administration, are now proposing new ideas like a "golden share" and "supervisory structures" to take over the utility. This shift exposes the government's earlier weak approach to the company's financial crisis, prompting the new Prime Minister to choose between nationalization, special administration, or a revised creditor deal.

Guardian Business
3 min de lectura
Novo Nordisk Sues Eli Lilly Over 'Misleading' Weight-Loss Drug Ads
En desarrollo·hace 3 horas

Novo Nordisk Sues Eli Lilly Over 'Misleading' Weight-Loss Drug Ads

Novo Nordisk is suing Eli Lilly, alleging "false and misleading" advertisements for its weight-loss and anti-diabetes treatments, Zepbound and Mounjaro. Novo Nordisk claims Lilly used outdated studies comparing its highest doses against lower doses of Novo Nordisk's drugs, creating a deceptive impression of superiority. Eli Lilly defends its ads, citing the Surmount-5 trial as the only direct comparison.

Guardian Business
1 min de lectura